Bivalirudin Anticoagulation in Extracorporeal Membrane Oxygenation (ECMO) for Severe Coronaviral Disease (COVID-19) Related Acute Respiratory Distress Syndrome (ARDS)

PURPOSE: ECMO as a bridge, is a potential option in patients with severe COVID-19 who develop respiratory failure despite maximal conventional therapy. Heparin has been the standard anticoagulant, but is associated with bleeding and thrombocytopenia. Bivalirudin has been successfully used as an alte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, S., Kamath, A., Kumar, P., Panda, S., Kori, S., Shah, U., Ravipati, S., Arora, S., John, P., Nagaraju, M., Rahulan, V., Dutta, P., Attawar, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(1070)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988627/
http://dx.doi.org/10.1016/j.healun.2022.01.1091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988627/
http://dx.doi.org/10.1016/j.healun.2022.01.1091

Ejemplares similares